A ground­break­ing can­cer drug nabs fast OK, giv­ing Eli Lil­ly boast­ing rights as a ri­val speeds close be­hind

Eli Lil­ly $LLY has scored the fast FDA ap­proval it was gun­ning for when the phar­ma gi­ant plunked down $8 bil­lion to ac­quire Loxo …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.